TrianglePUBLICATIONS · 11773179
Phase II trial of a single weekly intravenous dose of ranpirnase in patients with unresectable malignant mesothelioma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2002 Jan 1
- First author
- Mikulski SM
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Mikulski SM
- type
- Author
- name
- Costanzi JJ
- type
- Author
- name
- Vogelzang NJ
- type
- Author
- name
- McCachren S
- type
- Author
- name
- Taub RN
- type
- Author
- name
- Chun H
- type
- Author
- name
- Mittelman A
- type
- Author
- name
- Panella T
- type
- Author
- name
- Puccio C
- type
- Author
- name
- Fine R
- type
- Author
- name
- Shogen K
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Mikulski SM
- type
- Author
- name
- Costanzi JJ
- type
- Author
- name
- Vogelzang NJ
- type
- Author
- name
- McCachren S
- type
- Author
- name
- Taub RN
- type
- Author
- name
- Chun H
- type
- Author
- name
- Mittelman A
- type
- Author
- name
- Panella T
- type
- Author
- name
- Puccio C
- type
- Author
- name
- Fine R
- type
- Author
- name
- Shogen K
- type
- Author
- bibliography ids
- nci-bib-087b632d5b67f7c33be344c3
- book metadata
- content sha256
- 0fe5f157e1e29c049df3d1367de46792019e65abf51d9a4fee8ad9eda9e3eac9
- document type
- citation
- dois
- 10.1200/JCO.2002.20.1.274
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:11773179
- immutable id
- pubmed:11773179@0fe5f157e1e29c049df3d1367de46792019e65abf51d9a4fee8ad9eda9e3eac9
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- Source null
- issn print
- 0732-183X
- issue
- 1
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 274-81
- volume
- 20
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 11773179
- provenance
- batch id
- d4e82e28940c878dd0a2
- provider
- NCBI PubMed ESummary
- record sha256
- eeb48057f3a2d8b57becdce0437cc9192d376a4a6d0e95d438ec0ad292a67f2e
- response sha256
- 257c7530b1505623f6712628a73c1e9b8b3119838f4ec701e62de2dab9d87468
- retrieved at
- 2026-09-09T23:45:44.017762+00:00
- publication date
- display
- 2002 Jan 1
- precision
- day
- year
- 2002
- publication types
- Clinical Trial
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase II trial of a single weekly intravenous dose of ranpirnase in patients with unresectable malignant mesothelioma.
Preserved source evidence · Not medical advice